Podoplanin requires sialylated O-glycans for stable expression on lymphatic endothelial cells and for interaction with platelets.
about
Platelet adhesion to podoplanin under flow is mediated by the receptor CLEC-2 and stabilised by Src/Syk-dependent platelet signalling.Molecular analysis of the cumulus matrix: insights from mice with O-glycan-deficient oocytes.CLEC-2 in megakaryocytes is critical for maintenance of hematopoietic stem cells in the bone marrow.Pathological lymphangiogenesis is modulated by galectin-8-dependent crosstalk between podoplanin and integrin-associated VEGFR-3.Emerging roles of podoplanin in vascular development and homeostasis.Polypeptide N-Acetylgalactosaminyltransferase 13 Contributes to Neurogenesis via Stabilizing the Mucin-type O-Glycoprotein Podoplanin.Sialylation on O-glycans protects platelets from clearance by liver Kupffer cells.Analysis of mammalian O-glycopeptides - we have made a good start, but there is a long way to go.Evidence for Kaposi Sarcoma Originating from Mesenchymal Stem Cell through KSHV-induced Mesenchymal-to-Endothelial Transition.The small molecule luteolin inhibits N-acetyl-α-galactosaminyltransferases and reduces mucin-type O-glycosylation of amyloid precursor protein.Loss of mucin-type O-glycans impairs the integrity of the glomerular filtration barrier in the mouse kidney.Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis.Glucuronylated core 1 glycans are required for precise localization of neuromuscular junctions and normal formation of basement membranes on Drosophila muscles.
P2860
Q27342857-51BCAA1F-F74E-4E65-834F-1C030AA67BDBQ35423837-19CE3E5B-9AA3-4C0A-8E38-FD0D9D28A0ECQ36286028-A8ECBD6C-4E73-4078-A138-01CBFD1C2CFDQ36799205-8E7FEDB9-8BE1-4A0F-BCD9-79E703697037Q38615601-D89847B7-AE63-4F45-9525-5161F406C1DAQ38746279-71B42301-1A0E-44B9-8A07-0DA477D86242Q46215378-D5E1DFFB-F91C-4360-9E87-79C29C66883CQ46846034-294345AD-E988-4788-919B-AA0F2B819B29Q47601651-EEA92FE9-4C1B-4068-821E-52625C3D1622Q47613542-CD501099-3F4D-4E37-9BD9-D8DC819D78FDQ47904098-C8E69D41-0101-4DE8-9145-31FC0B9099D0Q48367537-43AB23B6-AB57-43DC-BEE5-2A97C00E43F1Q52369334-16DC1BD7-BFC7-4044-926F-481E76693D96
P2860
Podoplanin requires sialylated O-glycans for stable expression on lymphatic endothelial cells and for interaction with platelets.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Podoplanin requires sialylated ...... or interaction with platelets.
@ast
Podoplanin requires sialylated ...... or interaction with platelets.
@en
Podoplanin requires sialylated ...... or interaction with platelets.
@nl
type
label
Podoplanin requires sialylated ...... or interaction with platelets.
@ast
Podoplanin requires sialylated ...... or interaction with platelets.
@en
Podoplanin requires sialylated ...... or interaction with platelets.
@nl
prefLabel
Podoplanin requires sialylated ...... or interaction with platelets.
@ast
Podoplanin requires sialylated ...... or interaction with platelets.
@en
Podoplanin requires sialylated ...... or interaction with platelets.
@nl
P2093
P2860
P1433
P1476
Podoplanin requires sialylated ...... or interaction with platelets.
@en
P2093
Brett Herzog
Changgeng Ruan
Christopher West
J Michael McDaniel
Kesheng Dai
Padmaja Mehta-D'Souza
Rodger P McEver
Tadayuki Yago
P2860
P304
P356
10.1182/BLOOD-2014-04-572107
P407
P50
P577
2014-10-21T00:00:00Z